Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators

Figure 5

Anti-tumor effects of tPA and D-penicillamine in a human melanoma xenograft model. Nude mice xenografted with human melanoma BLM were treated with tPA, D-penicillamine, or a combination of tPA and D-penicillamine. Shown are mean tumor volumes of at least 5 mice/treatment modality plus/minus SD. A reduction in tumor growth of 58% was observed by applying the combination treatment schedule. Treatment schedules: : none; : D-penicillamine; : tPA; : tPA and D-penicillamine

Back to article page